Bank of New York Mellon Corp Buys 15,365 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

Bank of New York Mellon Corp grew its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 4.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 400,816 shares of the company’s stock after acquiring an additional 15,365 shares during the period. Bank of New York Mellon Corp’s holdings in LifeStance Health Group were worth $2,954,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Blue Trust Inc. raised its holdings in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in LifeStance Health Group by 31.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company’s stock valued at $169,000 after acquiring an additional 5,767 shares during the period. The Manufacturers Life Insurance Company grew its position in LifeStance Health Group by 10.5% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock worth $572,000 after purchasing an additional 7,798 shares during the period. Rhumbline Advisers lifted its holdings in LifeStance Health Group by 4.5% in the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company’s stock valued at $1,441,000 after acquiring an additional 8,487 shares during the period. Finally, MetLife Investment Management LLC grew its position in LifeStance Health Group by 14.3% during the third quarter. MetLife Investment Management LLC now owns 80,422 shares of the company’s stock valued at $563,000 after buying an additional 10,084 shares during the period. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company’s stock, valued at $2,344,689. The trade was a 5.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 6.60% of the company’s stock.

LifeStance Health Group Trading Up 0.1 %

LFST opened at $6.82 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. The stock’s 50 day moving average price is $7.73 and its 200-day moving average price is $7.34. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $8.61. The stock has a market cap of $2.62 billion, a price-to-earnings ratio of -26.23 and a beta of 1.27.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on LFST shares. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective for the company in a research report on Monday, December 16th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, LifeStance Health Group has an average rating of “Hold” and an average target price of $8.63.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.